TrialCirculation2012

Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.

Colin Cunnington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.